Lytix Biopharma As

Liv Tone Eliassen

John Sigurd Svendsen

Øystein Rekdal

Baldur Sveinbjørnsson

Gerd Berge

The present invention provides a cytotoxic 7 to 25 mer peptide with three or more cationic residues which has one or more non-genetic bulky and lipophilic amino acids, as well as esters, amides, salts and cyclic derivatives thereof as well as methods of preparing the peptides, pharmaceutical compositions containing them and their use as medicaments, particularly as antibacterions or antitumoral agents. In a preferred aspect, the invention provides the use of said peptides in a method of inducing adaptive immunity against tumor growth or establishment in a subject, as well as the use of other lytic agents in a method of inducing adaptive immunity in a subject.

Growing community of inventors

Kvaloysletta, Norway

Liv Tone Eliassen